GLASDEGIB

GLASDEGIB was reported 474 times

GLASDEGIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSITIONAL THERAPY 1 1.0000
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 4 0.0233
2 MYELOBLAST COUNT INCREASED 1 0.0130
3 MEGAKARYOCYTES DECREASED 1 0.0108
4 LARYNGEAL HAEMORRHAGE 1 0.0087
5 CORONARY OSTIAL STENOSIS 1 0.0079
6 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
7 CHLOROMA 3 0.0071
8 MITRAL VALVE SCLEROSIS 1 0.0058
9 CLOSTRIDIAL SEPSIS 1 0.0041
10 SYNOVIAL RUPTURE 1 0.0029
11 ENTEROBACTER SEPSIS 1 0.0027
12 ENDOMETRIAL HYPERTROPHY 1 0.0025
13 DEATH OF RELATIVE 1 0.0025
14 ENDOMETRIAL DISORDER 1 0.0024
15 LACK OF SPONTANEOUS SPEECH 1 0.0023
16 METASTASES TO BONE MARROW 1 0.0020
17 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
18 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
19 ENTERITIS INFECTIOUS 3 0.0018
20 CARDIORENAL SYNDROME 1 0.0017
21 PNEUMOCOCCAL SEPSIS 1 0.0015
22 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
23 DIFFERENTIATION SYNDROME 1 0.0014
24 LIVER ABSCESS 4 0.0012
25 PROCEDURAL HYPOTENSION 1 0.0012
26 TRANSFUSION REACTION 1 0.0011
27 MUSCLE SWELLING 1 0.0011
28 FEBRILE NEUTROPENIA 69 0.0010
29 CORONAVIRUS TEST POSITIVE 1 0.0010
30 BLAST CELL COUNT INCREASED 1 0.0010
31 PERIRECTAL ABSCESS 1 0.0009
32 HAEMORRHAGIC STROKE 7 0.0009
33 BLOODY DISCHARGE 1 0.0009
34 OPTIC NERVE INJURY 1 0.0009
35 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
36 HYPOCHLORAEMIA 1 0.0009
37 FEBRILE INFECTION 1 0.0008
38 NEUTROPENIC SEPSIS 6 0.0008
39 CLOSTRIDIUM COLITIS 1 0.0008
40 NEOPLASM PROGRESSION 28 0.0008
41 PNEUMONIA FUNGAL 3 0.0008
42 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
43 ISCHAEMIC HEPATITIS 1 0.0007
44 HOSPICE CARE 7 0.0007
45 GASTRITIS HAEMORRHAGIC 1 0.0007
46 FUNGAEMIA 1 0.0006
47 METABOLIC ALKALOSIS 1 0.0006
48 RESPIRATORY ALKALOSIS 1 0.0006
49 INFLAMMATORY MARKER INCREASED 3 0.0006
50 RECTAL ABSCESS 1 0.0006
51 ENTEROBACTER INFECTION 1 0.0006
52 BLOOD PH DECREASED 1 0.0006
53 SOFT TISSUE INFECTION 1 0.0005
54 BODY TEMPERATURE ABNORMAL 1 0.0005
55 HYPOREFLEXIA 1 0.0005
56 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
57 VENOUS THROMBOSIS LIMB 1 0.0005
58 GASTROINTESTINAL PERFORATION 2 0.0005
59 GASTROINTESTINAL ULCER 1 0.0005
60 CALCINOSIS 1 0.0004
61 LUMBAR VERTEBRAL FRACTURE 2 0.0004
62 ESCHERICHIA BACTERAEMIA 1 0.0004
63 CYTOPENIA 5 0.0004
64 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
65 LABYRINTHITIS 1 0.0004
66 PHYSICAL DECONDITIONING 1 0.0004
67 ACUTE MYELOID LEUKAEMIA 6 0.0004
68 MUCORMYCOSIS 1 0.0004
69 WHITE BLOOD CELL DISORDER 1 0.0004
70 HEPATOTOXICITY 8 0.0004
71 NEUTROPHIL COUNT ABNORMAL 1 0.0004
72 HERPES VIRUS INFECTION 2 0.0003
73 ESCHERICHIA SEPSIS 1 0.0003
74 BACTERAEMIA 4 0.0003
75 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
76 METABOLIC ENCEPHALOPATHY 1 0.0003
77 VENTRICULAR HYPOKINESIA 1 0.0003
78 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
79 BACTERIAL SEPSIS 1 0.0003
80 LYMPHOCYTE COUNT INCREASED 1 0.0003
81 MUCOSAL INFLAMMATION 8 0.0003
82 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
83 HYPERBILIRUBINAEMIA 3 0.0003
84 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
85 FOOD INTOLERANCE 1 0.0003
86 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
87 PULMONARY HAEMORRHAGE 2 0.0003
88 SEPTIC SHOCK 11 0.0003
89 FEBRILE BONE MARROW APLASIA 1 0.0002
90 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
91 MYOPATHY 2 0.0002
92 VASCULAR DEVICE INFECTION 1 0.0002
93 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
94 ROSACEA 1 0.0002
95 NON-SMALL CELL LUNG CANCER 1 0.0002
96 GASTROINTESTINAL TOXICITY 1 0.0002
97 ATELECTASIS 2 0.0002
98 ENTEROCOCCAL INFECTION 1 0.0002
99 STAPHYLOCOCCAL SEPSIS 1 0.0002
100 HYPERVOLAEMIA 1 0.0002
101 CORONARY ARTERY STENOSIS 1 0.0002
102 BLOOD COUNT ABNORMAL 3 0.0002
103 TASTE DISORDER 4 0.0002
104 PARTIAL SEIZURES 1 0.0002
105 BLOOD LACTIC ACID INCREASED 1 0.0002
106 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
107 PRODUCT RESIDUE PRESENT 1 0.0002
108 STRESS FRACTURE 1 0.0002
109 GASTRIC ULCER HAEMORRHAGE 1 0.0002
110 NEUTROPENIA 24 0.0002
111 MYOCARDITIS 2 0.0002
112 ENTEROCOLITIS 1 0.0002
113 METABOLIC DISORDER 1 0.0002
114 HYPOVOLAEMIA 1 0.0002
115 COVID-19 PNEUMONIA 2 0.0002
116 OLIGURIA 1 0.0002
117 ACUTE RESPIRATORY FAILURE 3 0.0002
118 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
119 PROCTALGIA 1 0.0002
120 TENDON DISORDER 1 0.0002
121 TERMINAL STATE 1 0.0001
122 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
123 FULL BLOOD COUNT DECREASED 3 0.0001
124 PNEUMONIA 48 0.0001
125 JOINT EFFUSION 1 0.0001
126 HYPERTRANSAMINASAEMIA 1 0.0001
127 PANCYTOPENIA 8 0.0001
128 RIGHT VENTRICULAR FAILURE 1 0.0001
129 HYPONATRAEMIA 8 0.0001
130 SUBDURAL HAEMATOMA 2 0.0001
131 GRAFT VERSUS HOST DISEASE 1 0.0001
132 MYELOSUPPRESSION 5 0.0001
133 UTERINE LEIOMYOMA 1 0.0001
134 HYPOPHOSPHATAEMIA 1 0.0001
135 SEPSIS 15 0.0001
136 PAROSMIA 1 0.0001
137 TROPONIN INCREASED 1 0.0001
138 DEATH 111 0.0001
139 POST PROCEDURAL INFECTION 1 0.0001
140 SECOND PRIMARY MALIGNANCY 1 0.0001
141 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
142 CIRCULATORY COLLAPSE 2 0.0001
143 DRUG RESISTANCE 3 0.0001
144 BLOOD MAGNESIUM DECREASED 1 0.0001
145 SPINAL OSTEOARTHRITIS 1 0.0001
146 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
147 HAEMARTHROSIS 1 0.0001
148 BLOOD BILIRUBIN INCREASED 3 0.0001
149 OSTEOMYELITIS 2 0.0001
150 PNEUMONITIS 3 0.0001
151 RESPIRATORY DISTRESS 3 0.0001
152 NERVE COMPRESSION 1 0.0001
153 ARTERIOSCLEROSIS 1 0.0001
154 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
155 COLITIS 4 0.0001
156 HAEMATOTOXICITY 1 0.0001
157 SLEEP APNOEA SYNDROME 2 0.0001
158 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
159 RENAL TUBULAR NECROSIS 1 0.0001
160 ACUTE MYOCARDIAL INFARCTION 3 0.0001
161 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
162 VENTRICULAR EXTRASYSTOLES 1 0.0001
163 TRANSFUSION 1 0.0001
164 FOLLICULITIS 1 0.0001
165 SUDDEN DEATH 1 0.0001
166 TRANSAMINASES INCREASED 2 0.0001
167 MITRAL VALVE INCOMPETENCE 1 0.0001
168 NEOPLASM 1 0.0001
169 DELIRIUM 3 0.0001
170 ELECTROLYTE IMBALANCE 1 0.0001
171 HYPOXIA 3 0.0001
172 PLATELET COUNT DECREASED 9 0.0001
173 PRODUCT PRESCRIBING ERROR 2 0.0001
174 CHOLECYSTITIS 1 0.0001
175 POLYNEUROPATHY 1 0.0001
176 GENERALISED OEDEMA 1 0.0001
177 DYSGEUSIA 6 0.0001
178 TOXICITY TO VARIOUS AGENTS 13 0.0001
179 RESPIRATORY TRACT INFECTION 2 0.0001
180 BLOOD CREATININE INCREASED 5 0.0001
181 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
182 GINGIVAL BLEEDING 1 0.0001
183 DIVERTICULITIS 2 0.0001
184 MENTAL STATUS CHANGES 2 0.0001
185 ORAL DISCOMFORT 1 0.0001
186 THROMBOCYTOPENIA 8 0.0001
187 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
188 RECTAL HAEMORRHAGE 3 0.0001
189 INFECTION 10 0.0001
190 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
191 HYPOKINESIA 1 0.0001
192 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
193 FLUID OVERLOAD 1 0.0001
194 IMMUNODEFICIENCY 1 0.0001
195 HAEMORRHAGE INTRACRANIAL 1 0.0001
196 MUSCULOSKELETAL CHEST PAIN 1 0.0001
197 LUNG INFECTION 1 0.0001
198 CYANOSIS 1 0.0001
199 PRODUCT USE COMPLAINT 1 0.0001
200 FUNGAL INFECTION 2 0.0001
201 DISEASE PROGRESSION 7 0.0001
202 ORTHOSTATIC HYPOTENSION 1 0.0001
203 CEREBRAL HAEMORRHAGE 2 0.0001
204 TOOTHACHE 1 0.0001
205 TREATMENT NONCOMPLIANCE 3 0.0001
206 HAEMATOCRIT DECREASED 1 0.0001
207 CYTOKINE RELEASE SYNDROME 1 0.0000
208 BONE MARROW FAILURE 1 0.0000
209 NEUTROPHIL COUNT DECREASED 2 0.0000
210 PERITONITIS 1 0.0000
211 PULMONARY HYPERTENSION 1 0.0000
212 ACUTE KIDNEY INJURY 7 0.0000
213 GLOSSODYNIA 1 0.0000
214 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
215 HYPOKALAEMIA 2 0.0000
216 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
217 DECREASED APPETITE 10 0.0000
218 PRODUCT USE ISSUE 8 0.0000
219 LOCALISED INFECTION 1 0.0000
220 PRESYNCOPE 1 0.0000
221 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
222 AGEUSIA 1 0.0000
223 CELLULITIS 2 0.0000
224 HAEMATEMESIS 1 0.0000
225 HYPOPHAGIA 1 0.0000
226 HAEMOGLOBIN DECREASED 4 0.0000
227 OFF LABEL USE 34 0.0000
228 ARTHRITIS 3 0.0000
229 HAEMATOCHEZIA 2 0.0000
230 TREATMENT FAILURE 3 0.0000
231 CEREBROVASCULAR ACCIDENT 6 0.0000
232 SEIZURE 4 0.0000
233 DYSSTASIA 1 0.0000
234 ASCITES 1 0.0000
235 CORONARY ARTERY DISEASE 1 0.0000
236 NERVOUS SYSTEM DISORDER 1 0.0000
237 DRUG-INDUCED LIVER INJURY 1 0.0000
238 ATRIAL FIBRILLATION 3 0.0000
239 URINARY RETENTION 1 0.0000
240 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
241 PYREXIA 10 0.0000
242 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
243 C-REACTIVE PROTEIN INCREASED 1 0.0000
244 RESPIRATORY FAILURE 2 0.0000
245 UNDERDOSE 2 0.0000
246 EPISTAXIS 2 0.0000
247 ANAEMIA 5 0.0000
248 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
249 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
250 ABNORMAL BEHAVIOUR 1 0.0000
251 DISORIENTATION 1 0.0000
252 CONFUSIONAL STATE 4 0.0000
253 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
254 OSTEOARTHRITIS 1 0.0000
255 HYPOACUSIS 1 0.0000
256 VAGINAL HAEMORRHAGE 1 0.0000
257 CONSTIPATION 5 0.0000
258 RENAL FAILURE 3 0.0000
259 TACHYCARDIA 2 0.0000
260 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
261 THERAPY NON-RESPONDER 1 0.0000
262 MUSCLE SPASMS 4 0.0000
263 ARRHYTHMIA 1 0.0000
264 DYSPHAGIA 2 0.0000
265 LEUKOPENIA 1 0.0000
266 HYPOTENSION 4 0.0000
267 THERAPY CESSATION 1 0.0000
268 ILLNESS 2 0.0000
269 PANCREATITIS 1 0.0000
270 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
271 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
272 OXYGEN SATURATION DECREASED 1 0.0000
273 MUSCULAR WEAKNESS 2 0.0000
274 URINARY TRACT INFECTION 3 0.0000
275 NASAL CONGESTION 1 0.0000
276 PLEURAL EFFUSION 1 0.0000
277 ALOPECIA 3 0.0000
278 BLOOD PRESSURE DECREASED 1 0.0000
279 DEHYDRATION 2 0.0000
280 WEIGHT DECREASED 4 0.0000
281 THERAPY INTERRUPTED 1 0.0000
282 DIARRHOEA 9 0.0000
283 HALLUCINATION 1 0.0000
284 UNEVALUABLE EVENT 1 0.0000
285 BACK PAIN 3 0.0000
286 DRUG INTERACTION 2 0.0000
287 CARDIAC FAILURE CONGESTIVE 1 0.0000
288 CARDIAC ARREST 1 0.0000
289 ABDOMINAL DISCOMFORT 2 0.0000
290 MYALGIA 2 0.0000
291 MALAISE 5 0.0000
292 CARDIAC DISORDER 1 0.0000
293 SWELLING 1 0.0000
294 ASTHENIA 4 0.0000
295 PULMONARY EMBOLISM 1 0.0000
296 NEUROPATHY PERIPHERAL 1 0.0000
297 GAIT DISTURBANCE 2 0.0000
298 DRUG INTOLERANCE 1 0.0000
299 NAUSEA 8 0.0000
300 SYNCOPE 1 0.0000
301 CHEST DISCOMFORT 1 0.0000
302 ARTHRALGIA 4 0.0000
303 ABDOMINAL DISTENSION 1 0.0000
304 INFLUENZA 1 0.0000
305 DEPRESSION 2 0.0000
306 ABDOMINAL PAIN 2 0.0000
307 DRUG INEFFECTIVE 10 0.0000
308 PRODUCT DOSE OMISSION ISSUE 2 0.0000
309 CONDITION AGGRAVATED 2 0.0000
310 HOSPITALISATION 1 0.0000
311 FATIGUE 5 0.0000
312 TREMOR 1 0.0000
313 FALL 2 0.0000
314 URTICARIA 1 0.0000
315 NO ADVERSE EVENT 1 0.0000
316 CHEST PAIN 1 0.0000
317 ERYTHEMA 1 0.0000
318 HYPERTENSION 1 0.0000
319 DIZZINESS 2 0.0000
320 DYSPNOEA 2 0.0000
321 RASH 1 0.0000
322 VOMITING 1 0.0000
323 PAIN 1 0.0000
324 HEADACHE 1 0.0000